Evidence map›Paper›PMID 41601692›Full record

ArticleFrontiers in immunology2025

An antibody uniquely binding short 2'-O-methyl RNA oligonucleotide duplexes: formation and recognition of target duplexes on cell surfaces.

Ian S Dunn, Matthew M Lawler, Leah Fagundes, Milto Simoes Junior, April Mangold, Domenic Rinaldi, Lenora B Rose, James T Kurnick

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ian S DunnTriBiotica LLC, Quincy, MA, United States.
Matthew M LawlerTriBiotica LLC, Quincy, MA, United States.
Leah FagundesTriBiotica LLC, Quincy, MA, United States.
Milto Simoes JuniorTriBiotica LLC, Quincy, MA, United States.
April MangoldTriBiotica LLC, Quincy, MA, United States.
Domenic RinaldiTriBiotica LLC, Quincy, MA, United States.
Lenora B RoseTriBiotica LLC, Quincy, MA, United States.
James T KurnickDepartment of Pathology, Massachusetts General Hospital, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the primary aim of generating antibody tools useful for diagnostic and therapeutic applications relevant to oligonucleotide-templated reactions, an scFv filamentous phage library was screened using a specific 2'-O-methyl RNA template:oligonucleotide click reaction complex as the target structure. Such an antibody would not be expected to recognize any naturally occurring biological molecules. Two promising candidate scFv clones were converted into human IgG1 antibodies for further characterization. Surprisingly, although the best antibody (IgG1-DS5) was bound to the original selection complex, its recognition preference was shown to be directed toward short 2'-O-methyl RNA duplexes without click modifications. The IgG1-DS5 antibody showed no binding to the separate single strands comprising the recognized duplex, nor to the corresponding duplexes with RNA or DNA template strands. Versions of the target 2'-O-methyl RNA duplex with divergent sequences were also not recognized by IgG1-DS5. The unexpected binding properties of the IgG1-DS5 antibody were directed toward potential applications based on the molecular proximity of tethered single strands. Initially, SKBr3 cells were coated with biotins by means of surface azide metabolic labeling with peracetylated N-azidoacetylmannosamine, followed by treatment with a click-reactive DBCO-PEG4-biotin compound. Subsequent cell treatment with the tetravalent biotin-binding protein neutravidin (NAV), carrying subsaturating levels of biotinylated 2'-O-methyl RNA target duplexes, showed strong IgG1-DS5 staining on cell surfaces. These observations were extended with biotinylated anti-EGFR antibody linked with biotinylated 2'-O-methyl RNA single strands, also by means of the NAV protein as an adaptor. Flow cytometry analysis showed that DS5 antibody binding was only obtained when combinations of separate preparations of antibodies carrying top and bottom target strands were applied sequentially to EGFR-positive cells. These results show that proximity-based surface annealing of the IgG1-DS5 antibody target single strands can act to define cell populations with a surface marker of sufficient density. Where IgG1-DS5 is derivatized with either a fluorescent moiety or a cytotoxic drug, this antibody may find application in diagnostic or therapeutic tumor targeting.

Indexed as

Immunoglobulin GOligonucleotidesRNASingle-Chain AntibodiesCell Line, TumorCell MembraneHumansRNA MethylationImmunoglobulin GOligonucleotidesRNASingle-Chain Antibodies2’-O-methyl RNA bindingcancer diagnosis and therapycell surface targetsshort duplex recognitionsurface annealingunique monoclonal antibody

Identifiers

PMID41601692
PMCPMC12833424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.